Rhinitis, Allergic, Seasonal: all 396 studies

Page 4 of 4. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.

• Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgECompletedNCT00755066Not applicable
• Probiotics for Birch Pollen AllergyCompletedNCT00746226Phase 1/2
• A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic RhinitisCompletedNCT00726401Phase 2
• Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP UnitsCompletedNCT00718744Phase 2
• Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male SubjectsCompletedNCT00694993Phase 1
• Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of SeasonCompletedNCT00688779Phase 1
• The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic RhinitisCompletedNCT00688441Phase 2
• Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)CompletedNCT00673062Phase 2
• To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)CompletedNCT00659841Phase 3
• Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)CompletedNCT00659594Phase 3
• Study Using the Environmental Exposure Unit (EEU) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-407)CompletedNCT00659503Phase 3
• To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)CompletedNCT00658918Phase 3
• To Determine if Diphenhydramine Works for Nasal Congestion at Two Different DosesCompletedNCT00648973Phase 4
• New Nasal Applicator / New Formulation - User StudyCompletedNCT00641979Phase 2
• Rhinocort Aqua Versus Placebo and Fluticasone PropionateCompletedNCT00641680Phase 3
• Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure UnitCompletedNCT00637611Phase 4
• Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight PersonnelCompletedNCT00637455Phase 4
• A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT00612820Phase 2
• A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic RhinitisCompletedNCT00612118Phase 2
• Acupuncture for Seasonal Allergic RhinitisCompletedNCT00610584Not applicable
• Investigation Of a New Oral Anti-Histamine in Healthy Male SubjectsCompletedNCT00605852Phase 1
• Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SARCompletedNCT00574379Phase 2
• PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)CompletedNCT00574210Phase 2
• Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)CompletedNCT00564421Phase 3
• A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic RhinitisCompletedNCT00561717Phase 4
• Montelukast as a Controller of Atopic SyndromeCompletedNCT00559546Phase 4
• Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive SubjectsCompletedNCT00544388Phase 3
• Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic RhinitisCompletedNCT00542607Phase 4
• An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00537355Phase 2
• MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)CompletedNCT00533208Phase 2
• To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic RhinitisCompletedNCT00525278Phase 3
• Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARCompletedNCT00521040Not applicable
• A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.CompletedNCT00517946
• Efficacy Study for the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00504933Phase 3
• Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum PratenseCompletedNCT00501527Phase 2
• Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic RhinitisStatus unknownNCT00488176Phase 4
• Effect of a Nasal Bolus Allergen Challenge on Inflammatory MarkersCompletedNCT00483353Phase 1
• Intranasal Steroids and the Nasal Ocular ResponseCompletedNCT00473915Phase 4
• A Randomized Study to Evaluate a Novel Method of Specific Allergen ImmunotherapyCompletedNCT00470457Phase 2
• Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis SymptomsCompletedNCT00460538Phase 4
• Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic RhinitisCompletedNCT00443495Phase 1/2
• Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00430157Phase 2
• Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass PollenCompletedNCT00426179Phase 1/2
• Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)CompletedNCT00423995Phase 3
• Twin SUBLIVAC® Grasses Clinical Efficacy StudyCompletedNCT00422149Phase 3
• A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge ChamberCompletedNCT00420082Phase 2
• A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic RhinitisCompletedNCT00407927Phase 2
• Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory InfectionsCompletedNCT00405899
• Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic RhinitisCompletedNCT00400998Phase 2
• Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1CompletedNCT00396149Phase 1
• Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic AdultsTerminatedNCT00387738Phase 2
• Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 2
• Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or PlaceboWithdrawnNCT00385463Not applicable
• A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)CompletedNCT00384475Phase 3
• Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00377728Phase 2
• Study of GW685698X In Patients With Seasonal Allergic RhinitisCompletedNCT00363740Phase 3
• Study Of Perennial Allergic RhinitisCompletedNCT00358475Phase 3
• DNA Vaccine for Ragweed Allergic AdultsCompletedNCT00346086Phase 2
• Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic RhinitisCompletedNCT00334698Not applicable
• Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic RhinitisCompletedNCT00325338Phase 2
• Effects of Loratadine/Montelukast vs Pseudoephedrine and Placebo in Patients With Seasonal Allergic Rhinitis (Study P04095) (COMPLETED)CompletedNCT00319995Phase 3
• Treatment of Ragweed-Allergic Asthma With an Immunostimulatory DrugTerminatedNCT00318747Phase 2
• Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00315523Phase 3
• Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic RhinoconjunctivitisCompletedNCT00309062Phase 3
• Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)CompletedNCT00305487Phase 3
• Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008Status unknownNCT00298337Phase 2/3
• A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal SecretionsCompletedNCT00297843
• Safety and Efficacy of an Allergen Vaccine in Grass-Pollen AllergyCompletedNCT00293904Phase 1/2
• Repeat Nasal Allergen ChallengeCompletedNCT00290368Phase 2
• Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FVCompletedNCT00266526Phase 2
• Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen MixtureCompletedNCT00264459Phase 3
• Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen AllergensCompletedNCT00263627Phase 3
• Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic RhinoconjunctivitisCompletedNCT00263601Phase 3
• Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)CompletedNCT00261287Phase 3
• Safety and Efficacy Study of rEV131 in Allergic RhinitisStatus unknownNCT00247520Phase 1/2
• Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic RhinitisCompletedNCT00227058Not applicable
• Study In Adults And Adolescents With Seasonal Allergic Rhinitis.CompletedNCT00225823Phase 3
• Seasonal Allergic Rhinitis and Driving AbilityTerminatedNCT00223587Phase 4
• The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure UnitCompletedNCT00209365Not applicable
• Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)CompletedNCT00197262Phase 3
• Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic DisordersCompletedNCT00189917Phase 1
• Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)CompletedNCT00163514Phase 3
• Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)CompletedNCT00163501Phase 3
• Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)CompletedNCT00163488Phase 3
• POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNCT00160537Phase 4
• Effects of Sublingual Immunotherapy on Grasspollen AllergyCompletedNCT00150514Phase 4
• Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and AsthmaCompletedNCT00135642Phase 3
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen HayfeverCompletedNCT00135629Phase 3
• An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)CompletedNCT00127647Phase 3
• Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
• Nasal Ocular Reflexes Contribute to Eye SymptomsCompletedNCT00117832Not applicable
• Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
• 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic RhinitisCompletedNCT00115089Phase 2
• Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3
• An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)CompletedNCT00092885Phase 3
• Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal AllergiesCompletedNCT00078195Phase 2

← Rhinitis, Allergic, Seasonal overview